Asarfi Hospital

113.00
-5.47
(-4.62%)
ann
There are new updates from the company6 hours ago
Viewcross
right
Market Cap
223.30 Cr
EPS
2.31
PE Ratio
21.13
Dividend Yield
0.00 %
52 Week High
122.00
52 Week Low
52.84
PB Ratio
2.76
Debt to Equity
0.45
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,177.10
#1 1,14,430.80
101.05
5,584.10
18.77
#1 1,058
26.84
57.57
7,064.50
1,01,576.70
77.51
#1 19,165.50
14.74
917
49.14
57.82
719.05
54,285.30
64.11
6,931.20
8.99
645
-7.43
61.88
1,724.40
35,240.00
#1 44.96
5,093.40
10.96
790
3.41
44.82
1,219.90
32,765.00
63.13
2,759.20
#1 25.09
326
-20.35
51.90
553.80
27,663.00
74.55
3,723.70
22.85
205
#1 3,986.36
56.75
672.90
26,925.30
71.59
2,511.20
12.94
336
48.39
60.33
1,352.30
13,732.80
57.70
1,334.00
10.76
218
10.57
45.37
1,459.30
9,568.00
49.50
1,095.50
21.32
177
-0.88
52.00
594.65
8,290.30
148.78
1,929.10
12.97
41
-71.06
55.43
Forecast
Actual
Growth Rate
Revenue Growth
17.85 %
Net Income Growth
-47.45 %
Cash Flow Change
3,376.00 %
ROE
-68.78 %
ROCE
-57.58 %
EBITDA Margin (Avg.)
-6.37 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Dec 2024
Mar 2025
Revenue
21
24
34
39
Expenses
16
20
26
29
EBITDA
5
4
8
10
Operating Profit %
20 %
16 %
21 %
15 %
Depreciation
3
4
3
3
Interest
1
1
1
1
Profit Before Tax
1
-1
4
5
Tax
1
-1
1
2
Net Profit
-0
-0
3
4
EPS in ₹
-0.03
-0.18
1.36
1.82

Balance Sheet

Balance Sheet
2024
Total Assets
154
Fixed Assets
94
Current Assets
47
Capital Work in Progress
0
Investments
0
Other Assets
60
Total Liabilities
154
Current Liabilities
42
Non Current Liabilities
42
Total Equity
70
Reserve & Surplus
51
Share Capital
20

Cash Flow

Cash Flow
2024
Net Cash Flow
-1
Investing Activities
-63
Operating Activities
26
Financing Activities
36

Share Holding

% Holding
Mar 2023
Jul 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Promoter
83.03 %
61.17 %
61.17 %
61.17 %
61.17 %
61.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.37 %
3.25 %
2.33 %
1.95 %
2.92 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
23.73 %
27.40 %
31.63 %
32.99 %
30.86 %
Others
16.97 %
14.74 %
8.18 %
4.87 %
3.89 %
5.05 %
No of Share Holders
37
1,248
706
1,261
1,284
1,262

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
08 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 May 2025 89.81 94.41
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 93.67 94.88
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 59.99 63.60
13 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
13 Sept 2024 62.88 63.15
30 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Jan 2024 83.07 94.14

Announcements

Integrated Filing (Financial)6 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 09, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th May 2025 And Submission Of Standalone & Consolidated Audited Financial Results For The Quarter Ended & Year Ended 31St March 2025 As Per SEBI (Listing Obligations And Disclosure Requirements)May 08, 2025
Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of SEBI Listing Regulations 2015.May 02, 2025
Closure of Trading WindowMar 29, 2025
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 28, 2025
Intimation Of Material Event-High Court Jharkhand Order Civil Litigation Related To Cancer Hospital Land.Mar 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 31, 2025
Outcome Of Board Meeting Held On 31St January 2025 And Submission Of Unaudited Financial Results For The Quarter Ended 31St December 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Jan 31, 2025
Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of SEBI Listing Regulations 2015 To Consider And Approve The Unaudited Financial Results For The Quater Ended 31St Dec2025.Jan 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 01, 2024
Intimation Of Material Event - Possession & Registry Of Land.Nov 01, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 30, 2024
Outcome Of Board Meeting Held On 30Th October, 2024 And Submission Of Unaudited Financial Results For The Half Year Ended 30Th September, 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Oct 30, 2024
Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of SEBI Listing Regulations, 2015.Oct 22, 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public IssueOct 10, 2024
Announcement Regarding Expansion Of Services Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Oct 10, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement) 2015.Oct 07, 2024
Announcement Regarding Grant Of Approval From Pharmacy Council Of India For D. Pharm Course Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,Sep 30, 2024
Closure of Trading WindowSep 26, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 14, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 13, 2024
Intimation Regarding Revision In Credit Rating.Sep 09, 2024
Additional Disclosure As Required Under Regulation 30 Of SEBI (LODR) Regulations,2015.Aug 23, 2024
Reg. 34 (1) Annual Report.Aug 22, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing ObligationAnd Disclosure Requirement) 2015.Aug 20, 2024
Board Meeting Intimation for BOARD MEETINGAug 13, 2024
Disclosure Of The Impact Of Audit Qualifications On Asarfi Hospital Limited Standalone & Consolidated Financial Statements.Jul 04, 2024
Announcement Under Regulation 30 Of LODR Regulation, 2015 Regarding Board Comment On SDD Non-ComplianceJun 22, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Jun 19, 2024
IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024Jun 13, 2024
IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024Jun 13, 2024
Intimation Relating To Disposal Of Appeal Filed (Civil Appeal 6781-6782 / 2023) In Hon'Ble Supreme Court Of India In Favour Of Asarfi Hospital Limited Filed Against The Order Of The Hon'Ble High Court In FA 43 Of 2012 Relating To Land Allotted ByState Of Jharkhand For Establishment Of Cancer Hospital.Jun 06, 2024
Audited Results For 31.03.2024May 09, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May 2024 And Submission OfUnaudited Financial Results For The Half Year And Year Ended 31St March 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.May 06, 2024
Board Meeting Intimation for Adopting The Unaudited Financial Results For The Half Year And Year Ending 31 March 2024.Apr 29, 2024
Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Apr 29, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 16, 2024
Closure of Trading WindowApr 16, 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Issue.Apr 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 11, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Apr 10, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBIMar 27, 2024

Technical Indicators

RSI(14)
Neutral
68.46
ATR(14)
Volatile
6.36
STOCH(9,6)
Overbought
88.14
STOCH RSI(14)
Neutral
79.28
MACD(12,26)
Bullish
2.10
ADX(14)
Strong Trend
30.06
UO(9)
Bearish
69.51
ROC(12)
Uptrend And Accelerating
20.19
WillR(14)
Neutral
-26.66